Lipidomics: a promising cancer biomarker
Abstract The prevention, diagnosis and targeted therapies of cancer are important in cancer controlling and treatment. The present challenge about cancer biomarker still remains in identifying the special biomarkers for predicting cancer risk and assessing patient’s response during anticancer treatm...
Main Authors: | Furong Yan, Hong Zhao, Yiming Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-07-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40169-018-0199-0 |
Similar Items
-
Lipidomic Biomarkers in Polycystic Ovary Syndrome and Endometrial Cancer
by: Mohamad Nasir Shafiee, et al.
Published: (2020-07-01) -
Clinical lipidomics: a new way to diagnose human diseases
by: Jiapei Lv, et al.
Published: (2018-04-01) -
Advances in Lipidomics for Cancer Biomarkers Discovery
by: Francesca Perrotti, et al.
Published: (2016-11-01) -
Perturbations of Lipid Metabolism Indexed by Lipidomic Biomarkers
by: Antonin Lamaziere, et al.
Published: (2012-01-01) -
Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma
by: Sureerat Padthaisong, et al.
Published: (2021-08-01)